These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9661650)

  • 1. A variant of paraoxonase (PON1) gene is associated with diabetic retinopathy in IDDM.
    Kao YL; Donaghue K; Chan A; Knight J; Silink M
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2589-92. PubMed ID: 9661650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes.
    Kao Y; Donaghue KC; Chan A; Bennetts BH; Knight J; Silink M
    Diabet Med; 2002 Mar; 19(3):212-5. PubMed ID: 11918623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus.
    Kordonouri O; James RW; Bennetts B; Chan A; Kao YL; Danne T; Silink M; Donaghue K
    Metabolism; 2001 Jun; 50(6):657-60. PubMed ID: 11398141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-speed detection of the two common paraoxonase polymorphisms Leu55-->Met and Gln192-->Arg by real-time fluorescence PCR and melting curves.
    Harangi M; Aslanidis C; Paragh G; Schmitz G
    Clin Chem Lab Med; 2002 Apr; 40(4):337-40. PubMed ID: 12059071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes.
    Koch M; Hering S; Barth C; Ehren M; Enderle MD; Pfohl M
    Exp Clin Endocrinol Diabetes; 2001; 109(3):141-5. PubMed ID: 11409295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in type I diabetes mellitus.
    Araki S; Makita Y; Canani L; Ng D; Warram JH; Krolewski AS
    Diabetologia; 2000 Dec; 43(12):1540-3. PubMed ID: 11151764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease].
    Taşkiran P; Cam SF; Sekuri C; Tüzün N; Alioğlu E; Altintaş N; Berdeli A
    Turk Kardiyol Dern Ars; 2009 Oct; 37(7):473-8. PubMed ID: 20098041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of Paraoxonase (PON1) locus reveals an increased frequency of Arg192 allele in centenarians.
    Bonafè M; Marchegiani F; Cardelli M; Olivieri F; Cavallone L; Giovagnetti S; Pieri C; Marra M; Antonicelli R; Troiano L; Gueresi P; Passeri G; Berardelli M; Paolisso G; Barbieri M; Tesei S; Lisa R; De Benedictis G; Franceschi C
    Eur J Hum Genet; 2002 May; 10(5):292-6. PubMed ID: 12082503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.
    Boemi M; Leviev I; Sirolla C; Pieri C; Marra M; James RW
    Atherosclerosis; 2001 Mar; 155(1):229-35. PubMed ID: 11223446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients.
    Leus FR; Zwart M; Kastelein JJ; Voorbij HA
    Atherosclerosis; 2001 Feb; 154(3):641-9. PubMed ID: 11257265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
    Pfohl M; Koch M; Enderle MD; Kühn R; Füllhase J; Karsch KR; Häring HU
    Diabetes; 1999 Mar; 48(3):623-7. PubMed ID: 10078566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between PON 1 polymorphisms, PON activity and diabetes complications.
    Hofer SE; Bennetts B; Chan AK; Holloway B; Karschimkus C; Jenkins AJ; Silink M; Donaghue KC
    J Diabetes Complications; 2006; 20(5):322-8. PubMed ID: 16949520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus.
    Mackness B; Mackness MI; Arrol S; Turkie W; Julier K; Abuasha B; Miller JE; Boulton AJ; Durrington PN
    Atherosclerosis; 1998 Aug; 139(2):341-9. PubMed ID: 9712341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
    Garin MC; James RW; Dussoix P; Blanché H; Passa P; Froguel P; Ruiz J
    J Clin Invest; 1997 Jan; 99(1):62-6. PubMed ID: 9011577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?
    Fekih O; Triki S; Hellara I; Neffati F; Rejeb J; Ommezzine A; Chouchane S; Guediche MN; Bouslama A; Najjar MF
    J Clin Lipidol; 2014; 8(3):249-55. PubMed ID: 24793345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls.
    Mackness B; Durrington PN; Boulton AJ; Hine D; Mackness MI
    Eur J Clin Invest; 2002 Apr; 32(4):259-64. PubMed ID: 11952811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients.
    Leviev I; Kalix B; Brulhart Meynet MC; James RW
    Diabetologia; 2001 Sep; 44(9):1177-83. PubMed ID: 11596674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease.
    Carmine A; Buervenich S; Sydow O; Anvret M; Olson L
    Mov Disord; 2002 Jul; 17(4):764-6. PubMed ID: 12210872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
    Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
    Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.